Afterwards, there will be the opportunity to take part in a guided tour covering start-ups and innovation topics. The “grand finale” will be the get-together during the MEDICA START-UP NIGHT. Women interested in attending the “Women leaders in healthcare” session can find all the relevant details at https://www.medica-tradefair.com/mif2.
More than just skin and bones: what bio-printers can produce
The stage program on November 13 (starting at 11 :00 am) will highlight the topic of 3D printing - innovative prosthetics, orthotics and similar applications. Nowadays, printing various biological materials, up to and including organs, is either already possible or in development. Manuel Figueruela, CEO of Regemat3D, will report on this. Regemat3D designs, develops and manufactures 3D bio-printing systems and bio-reactors. In collaboration with more than 200 research groups in over 35 countries, they produce human tissue such as skin, cartilage, cornea, bone or heart tissue for implantation purposes. Robert Moebius is a lab manager at Biosaxony’s Medical Forge start-up program, which works with industry partners such as HP. As O&P Global Leader, Ayelén Fernaìndez from HP will focus on the field of orthopedic technology and prosthetics.
Starting at 1:00 pm, the “Future of Therapy” will be the topic at the forum. The series of talks will range from digital tools for home patient care to robot-assisted surgery, rehabilitation and assistive technologies.
The final day of the MEDICA INNOVATION FORUM will be dedicated to internationality, when healthcare hubs from Finland, France, Germany, Taiwan and Japan will present themselves. This will also provide a perfect connection to the MEDICA START-UP PARK in the immediate vicinity of the forum stage. Start-ups from all over the world will present their innovations for healthcare here, including Germany, Italy, India, Japan, Taiwan, Switzerland and the U.S.
For information about MEDICA 2024 as well as all the themed forums, special shows and exhibitors: https://www.medica-tradefair.com.
Author: Dr. Lutz Retzlaff, Medical Journalist (Neuss, Germany)
Back to HCB News
